ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print October 18, 2006
Eur Respir J 2006, doi:10.1183/09031936.00023606
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
29/1/51    most recent
09031936.00023606v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kinnula, V.L.
Right arrow Articles by Rytilä, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinnula, V.L.
Right arrow Articles by Rytilä, P.


ORIGINAL ARTICLE

8-isoprostane as a marker of oxidative stress in non-symptomatic cigarette smokers and COPD

V.L. Kinnula 1*, H. Ilumets 1, M. Myllärniemi 1, A. Sovijärvi 2, P. Rytilä 3

1 Dept of Medicine and Divisions of Pulmonary Medicine
2 Clinical Physiology and
3 Allergology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland

* To whom correspondence should be addressed. E-mail: vuokko.kinnula{at}helsinki.fi.


   Abstract

8-Isoprostane is a potential in vivo marker for oxidant burden, but its usefulness in induced sputum of smokers and COPD has not been investigated.

We investigated 58 subjects, i.e. 11 never smokers, 11 ex-smokers, 13 healthy current smokers, 23 COPD patients with Stage 0-III disease (GOLD criteria). 8-Isoprostane was determined from induced sputum by enzyme immunoassay.

Sputum 8-isoprostane levels were similar in the never-smokers and ex-smokers, but were elevated in the healthy smokers compared to non-smokers (p=0.005) and in Stage I-III COPD (p<0.0001 vs non-smokers and p=0.02 vs healthy smokers). Sputum 8-isoprostane levels could not differentiate non- symptomatic smokers from those with Stage 0 COPD. There was a correlation between the sputum 8-isoprostane level and lung function parameters (FEV1/FVC r= -0.66, p<0.0001) and sputum neutrophils (r=0.37, p=0.02).

The sputum 8-isoprostane level correlates with the severity of COPD. However, it does not appear to differentiate healthy smokers from those who are at risk for developing COPD (GOLD Stage 0).

Keywords:  Cigarette smoking, COPD, oxidant, sputum




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F.-C. Cheah, J. J. Pillow, B. W. Kramer, G. R. Polglase, I. Nitsos, J. P. Newnham, A. H. Jobe, and S. G. Kallapur
Airway inflammatory cell responses to intra-amniotic lipopolysaccharide in a sheep model of chorioamnionitis
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L384 - L393.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Brindicci, K. Ito, O. Torre, P. J. Barnes, and S. A. Kharitonov
Effects of Aminoguanidine, an Inhibitor of Inducible Nitric Oxide Synthase, on Nitric Oxide Production and Its Metabolites in Healthy Control Subjects, Healthy Smokers, and COPD Patients
Chest, February 1, 2009; 135(2): 353 - 367.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. G. Kelsen, X. Duan, R. Ji, O. Perez, C. Liu, and S. Merali
Cigarette Smoke Induces an Unfolded Protein Response in the Human Lung: A Proteomic Approach
Am. J. Respir. Cell Mol. Biol., May 1, 2008; 38(5): 541 - 550.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the European Respiratory Society.